Publications by authors named "David Fenwick"

Claim this Profile
B
Black-box Optimization of CT Acquisition and Reconstruction Parameters: A Reinforcement Learning Approach.
David Fenwick, Navid NaderiAlizadeh, Vahid Tarokh, Darin Clark, Jayasai Rajagopal

Proc SPIE Int Soc Opt Eng· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery and optimization of benzimidazoles as selective Na1.8 blockers for the treatment of pain.
Alan D Brown, Sharan K Bagal, Paul Blackwell, David C Blakemore, Bruce Brown, David R Fenwick

Bioorg Med Chem· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Invasive Nemertean Species () in England with High Levels of Tetrodotoxin and a Microbiome Linked to Toxin Metabolism.
Andrew D Turner, David Fenwick, Andy Powell, Monika Dhanji-Rapkova, Charlotte Ford

Mar Drugs· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematics of stalked jellyfishes (Cnidaria: Staurozoa).
Lucília S Miranda, Yayoi M Hirano, Claudia E Mills, Audrey Falconer, David Fenwick

PeerJ· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An imidazopiperidine series of CCR5 antagonists for the treatment of HIV: the discovery of N-{(1S)-1-(3-fluorophenyl)-3-[(3-endo)-3-(5-isobutyryl-2-methyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]propyl}acetamide (PF-232798).
Paul A Stupple, David V Batchelor, Martin Corless, Patrick K Dorr, David Ellis, David R Fenwick

J Med Chem· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An in situ oxidation strategy towards overcoming hERG affinity.
David C Pryde, Rhys Jones, Donald S Middleton, Ben J Laverty, David R Fenwick

Bioorg Med Chem Lett· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Catalytic enantio- and diastereoselective alkylations with cyclic sulfamidates.
Thomas A Moss, Beatriz Alonso, David R Fenwick, Darren J Dixon

Angew Chem Int Ed Engl· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a small molecule inhibitor through interference with the gp120-CD4 interaction.
David H Williams, Fiona Adam, David R Fenwick, Juin Fok-Seang, Iain Gardner

Bioorg Med Chem Lett· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and optimisation of potent gp120-CD4 inhibitors.
Thien-Duc Tran, Fiona M Adam, Frederick Calo, David R Fenwick, Juin Fok-Seang

Bioorg Med Chem Lett· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knowing - or not knowing - when to stop: cognitive decline in ageing doctors. Comment.
David G Fenwick

Med J Aust· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The design and discovery of novel amide CCR5 antagonists.
David C Pryde, Martin Corless, David R Fenwick, Helen J Mason, Blanda C Stammen

Bioorg Med Chem Lett· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enantio- and diastereoselective catalytic alkylation reactions with aziridines.
Thomas A Moss, David R Fenwick, Darren J Dixon

J Am Chem Soc· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis